Nifty Pharma Prediction for Tomorrow, Monday 13 July 2026: Index Closes 0.07 Percent Higher at 25,674.10 as Leadership Extends
- July 12, 2026
- Posted by: Ankit Jaiswal
- Category: News
Nifty Pharma prediction for tomorrow, Monday 13 July 2026: close 25,674.10, +0.07%. Day range 25,444.20 to 25,779.40. Support 25,440. Resistance 25,780.
The nifty pharma prediction for tomorrow, Monday 13 July 2026, is positive after the Nifty Pharma index closed at 25,674.10 today, Friday 10 July 2026, up 17.85 points or 0.07 percent, within a day range of 25,444.20 to 25,779.40. Today’s boundaries and constituent moves frame the nifty pharma prediction for tomorrow.
Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, have shared their nifty pharma prediction for tomorrow for Monday 13 July 2026 using today’s closing data and global cues.
Click Here – Get Free Investment Predictions
Today’s Session Recap Behind the Nifty Pharma Prediction for Tomorrow
- Sector session: The index opened at 25,681.70, touched a high of 25,779.40 and a low of 25,444.20, and closed at 25,674.10 against a previous close of 25,656.25. Among constituents, Sun Pharma, Cipla and Dr Reddy’s were largely steady today, with the sector barely positive as cyclical sectors like IT and metals captured most of today’s buying interest.
- In the broader market, the Nifty 50 closed at 24,206.90, up 1.02 percent, the Sensex rose 1.08 percent to 77,569.39, and the Bank Nifty gained 1.39 percent to 58,045.90, extending Thursday’s relief rally into a second strong session. ICICI Bank rose 1.48 percent and Reliance Industries added 2.19 percent, while HDFC Bank gained 0.91 percent. India VIX eased 8.30 percent to 12.25, nearly back to pre selloff levels. Markets are closed Saturday and Sunday, so Monday 13 July is the next trading session.
Key Levels in the Nifty Pharma Prediction for Tomorrow
Trend: Bullish. Support levels: 25,440 and 25,300. Resistance levels: 25,780 and 25,940.
For the nifty pharma prediction for tomorrow, today’s low makes 25,440 the first support, with 25,300 below it. Resistance sits at 25,780, near today’s high, and then 25,940. The 52 week range of 21,149.90 to 26,022.75 provides the wider context. A sustained move above 25,780 would extend the leadership trade tomorrow.
Key Drivers Shaping the Nifty Pharma Prediction for Tomorrow
- Nearly flat amid strong cyclical rotation: With IT, metals and financials all rallying sharply today, defensive pharma saw limited fresh buying.
- Still near the 52 week high: The sector remains within close range of its recent yearly peak of 26,022.75 despite today’s muted move.
- Export and biosimilar optimism intact: US generic pricing stability and biosimilar pipelines continue to support the medium term earnings outlook regardless of today’s rotation.
Index Data and Derivatives Snapshot
The snapshot below captures today’s index data for the sector:
| Metric | Value |
|---|---|
| Close | 25,674.10 |
| Change | 17.85 points (+0.07%) |
| Open | 25,681.70 |
| Day High | 25,779.40 |
| Day Low | 25,444.20 |
| Previous Close | 25,656.25 |
| 52 Week High | 26,022.75 |
| 52 Week Low | 21,149.90 |
Derivatives view: Sun Pharma, Cipla and Dr Reddy’s stock futures are among the liquid pharma contracts, and their F&O positioning guides the sector since the pharma index has no derivatives of its own.
Explore SEBI Registered Investment Advisory on Univest
Trading Strategy for Tomorrow
- Buy dips near 25,440: Entries near support offer better risk to reward than chasing strength at 25,780.
- Track the leaders: Constituent heavyweights drive this basket; follow their stock futures flows for intraday confirmation.
- Respect the invalidation: A close below 25,300 would negate the bullish setup tomorrow.
- Mind the fresh short positioning: Nifty and Bank Nifty futures both showed sharp fresh short buildup today; whether this extends or unwinds tomorrow will be a key signal.
What Does Sentiment Indicate for the Nifty Pharma Prediction for Tomorrow?
Sentiment in the nifty pharma prediction for tomorrow reflects today’s relative performance. Ankit Jaiswal notes that the sector participated fully in todays broad based relief rally following Wednesdays sharp selloff, a healthy sign of demand returning.
Kunal Singla observes that with India VIX at 11.65, a fresh multi month low, and FIIs net buyers in Friday’s cash session, the market backdrop supports continuation, making dips in this sector buyable while 25,440 holds in the nifty pharma prediction for tomorrow.
Risks to the Nifty Pharma Prediction for Tomorrow
- Weekend global developments: With markets closed Saturday and Sunday, any fresh news over the weekend, from geopolitics to global markets, will only be reflected when trading resumes Monday, a genuine gap risk.
- Elevated volatility persisting: With India VIX up nearly 25 percent today, expect continued sharp swings until the market finds a clearer direction.
- Constituent concentration: A reversal in the basket’s heaviest stocks can swing the index beyond the stated levels.
- Earnings season repricing: Q1 FY27 results starting this week can reset sector expectations quickly.
Download the Univest iOS App or Univest Android App to track live sector index levels and get daily predictions.
Conclusion: Nifty Pharma Prediction for Tomorrow
The nifty pharma prediction for tomorrow, Monday 13 July 2026, from Univest analysts Ankit Jaiswal and Kunal Singla is bullish with a buy on dips stance. The index closed at 25,674.10 (+0.07 percent) and is expected to trade between 25,440 and 25,940, with 25,300 as the invalidation level for the positive view. Constituent stock futures flows and tomorrow’s fresh weekly cycle are the factors to track. Check back after tomorrow’s close for the next nifty pharma prediction update from Univest analysts.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on the Nifty Pharma Prediction for Tomorrow
What is the nifty pharma prediction for tomorrow, Monday 13 July 2026?
Ans. The nifty pharma prediction for tomorrow, Monday 13 July 2026, is bullish. The index closed at 25,674.10 today, up 0.07 percent, and is expected to trade in a 25,440 to 25,940 range with support at 25,440 and 25,300 and resistance at 25,780 and 25,940.
What are the key levels in the nifty pharma prediction for tomorrow?
Ans. For the nifty pharma prediction for tomorrow, immediate support is at 25,440, near today’s low of 25,444.20, followed by 25,300. Resistance sits at 25,780, near today’s high of 25,779.40, and then 25,940.
Which stocks drive the nifty pharma prediction for tomorrow?
Ans. Constituent moves shape the nifty pharma prediction for tomorrow. Today, Sun Pharma, Cipla and Dr Reddy’s were largely steady today, with the sector barely positive as cyclical sectors like IT and metals captured most of today’s buying interest.
Does the index have futures and options for the nifty pharma prediction for tomorrow?
Ans. Sun Pharma, Cipla and Dr Reddy’s stock futures are among the liquid pharma contracts, and their F&O positioning guides the sector since the pharma index has no derivatives of its own.
What drove today’s move in the nifty pharma prediction for tomorrow?
Ans. Todays continued market wide rally, extending Thursdays relief bounce after Wednesdays sharp selloff, lifted the sector alongside most of the market. Markets are closed Saturday and Sunday, so any fresh developments will only be reflected when trading resumes Monday 13 July.
Is the nifty pharma prediction for tomorrow investment advice?
Ans. No. The nifty pharma prediction for tomorrow is educational content only. All levels are analyst observations, not recommendations. Univest is a SEBI registered research analyst (INH000013776) and readers should consult a SEBI registered advisor before acting on any view.
